Clinical Trials Browser

Recurrence × Tamoxifen × Clear all

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT00001436 2008-03-04

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

Phase 1 Completed

Neoplasm Metastasis, Recurrence, Osteosarcoma